Alzheimer's Disease: Pathogenesis, Diagnostics and Novel Treatment Options

Dear Colleagues,

For this Special Issue, we invite manuscripts focusing on Alzheimer’s disease (AD) on a variety of topics, ranging from fundamental pathophysiological mechanisms studies to clinical proof of concept and proof of mechanism studies. We encourage submissions focusing on the basic science on AD pathogenesis, including but not limited to the roles of amyloid and tau pathologies, neuroinflammation, mitochondrial dysfunction, and synaptic dysfunction. Cutting-edge research on diagnostics is welcome, such as fluid biomarkers (e.g. novel CSF and blood tests) and neuroimaging modalities. Studies leveraging AI-based diagnostics and machine learning for early identification and prognostication of AD are particularly encouraged. On the therapeutic front, we seek reports on all innovative strategies, including preclinical pharmacology or clinical studies, empirical and mechanistic modeling, as well as meta-analyses on promising disease-modifying therapies encompassing all modalities (such as small molecules, antibodies, and gene therapy).

We cordially invite authors to submit original research and review articles that focus on these important topics in AD research, aiming to foster a holistic understanding and highlight advances in diagnostics and therapies that will ultimately translate into improved outcomes for patients with AD. 

Dr. Rui Zhong
Prof. Dr. Ling Li
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.